Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study)

OBJECTIVE: To compare the efficacy and safety between tocilizumab added to methotrexate and tocilizumab switched from methotrexate in patients with active rheumatoid arthritis (RA). METHODS: This is a 2-year randomised, controlled study. RA patients with moderate or high disease activity despite met...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ann Rheum Dis
Main Authors: Kaneko, Yuko, Atsumi, Tatsuya, Tanaka, Yoshiya, Inoo, Masayuki, Kobayashi-Haraoka, Hitomi, Amano, Koichi, Miyata, Masayuki, Murakawa, Yohko, Yasuoka, Hidekata, Hirata, Shintaro, Nagasawa, Hayato, Tanaka, Eiichi, Miyasaka, Nobuyuki, Yamanaka, Hisashi, Yamamoto, Kazuhiko, Takeuchi, Tsutomu
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2016
Teme:
Clinical and Epidemiological Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5099201/
https://ncbi.nlm.nih.gov/pubmed/26733110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2015-208426
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki